The Answers You Wanted On Sepsis – Episode 3

 

 

In episode three of The Michael Rothman Podcast, Dr. Rothman continues his deep dive into sepsis—a condition often misunderstood yet responsible for a significant portion of hospital deaths. Through data from a major northeastern hospital, he challenges traditional thinking: labeling a patient as “septic” isn’t what determines survival—their overall sickness is. Using the Rothman Index, a patient acuity score he co-created, Rothman shows that acuity levels, not diagnostic flags, are the strongest predictors of mortality. His research reveals that whether or not patients were identified as septic, their outcomes aligned almost entirely with how sick they were upon admission. This insight reframes sepsis care from chasing labels to tracking decline, emphasizing that early recognition of deterioration can save lives. Rothman’s “trifecta of warning”—being correct, timely, and new—highlights the true value of predictive tools in medicine. In a field where seconds count, his message is both data-driven and deeply human: saving lives starts with seeing sickness before it’s too late.

Recent Episodes

Healthcare is being pushed to modernize faster than ever, as AI tools, virtual care, and digital patient experiences shift from innovation to expectation. Recent survey data from McKinsey & Company indicates that about half of U.S. healthcare leaders say their organizations have already put generative AI into practice, underscoring how quickly the technology is…

The U.S. healthcare system is under real strain—and it’s something both patients and physicians are feeling in everyday care. In Texas, those pressures are even more visible, where rapid population growth, rural access challenges, and regulatory complexity are making it harder for patients to get timely care and for doctors to focus on medicine…

Heart disease remains the leading cause of death in the U.S., with 683,491 deaths reported in 2024, according to the CDC. As cardiovascular care shifts toward access, prevention, and value-based outcomes, noninvasive therapies are gaining renewed attention for patients who continue to experience symptoms after traditional interventions. At the same time, rising healthcare costs…